Wednesday, October 24, 2012
Biosensors
Biosensors: announces the 5-yr results from the LEADERS trial at a symposium in The Netherlands, showing improved long term clinical outcomes for BioMatrix Flex, Biosensors’ Biolimus A9-eluting stent system with a biodegradable polymer coating, compared to Cypher Select, a competing product by Johnson & Johnson.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment